Skip to main content

Screening protocol to determine high risk cytogenetic features in previously treated CLL

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

TG Therapeutics, Inc

Start Date

July 1, 2016

End Date

October 19, 2017
 

Administered By

Duke Cancer Institute

Awarded By

TG Therapeutics, Inc

Start Date

July 1, 2016

End Date

October 19, 2017